CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Alkermes Pharma Ireland against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Injectable Long-Acting Naltrexone Microparticle CompositionsCHONG KUN DANG PHARMACEUTICALNov 6, 2024
Risperidone Sustained Release Microsphere CompositionGENEORA PHARMA SHIJIAZHUANGJul 7, 2021
Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemDRUGGABILITY HOLDCONov 11, 2020
Risperidone Sustained Release Microsphere CompositionNANJING LUYE PHARMACEUTICALApr 17, 2020
Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemDRUGGABILITY HOLDCO JERSEYJun 27, 2018
Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release ProfilePHARMATHENApr 26, 2018

Explore Alkermes Pharma Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 28, 2022Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders1
May 18, 2022Aripiprazole Prodrug Compositions1
May 12, 2021Monomethylfumarate Prodrug Compositions4
Jun 6, 2018Prodrugs Of Fumarates And Their Use In Treating Various Deseases3

Top competitors of Alkermes Pharma Ireland

List of top competitors of Alkermes Pharma Ireland based on patent oppositions.